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The spatiotemporally resolved monitoring of membrane translocation, e.g., of drugs or toxins,
has been a long-standing goal. Herein, we introduce the fluorescent artificial receptor-based
membrane assay (FARMA), a facile, label-free method. With FARMA, the permeation of
more than hundred organic compounds (drugs, toxins, pesticides, neurotransmitters, pep-
tides, etc.) through vesicular phospholipid bilayer membranes has been monitored in real
time (µs-h time scale) and with high sensitivity (nM-µM concentration), affording perme-
ability coefficients across an exceptionally large range from 10–9–10–3 cm s–1. From a fun-
damental point of view, FARMA constitutes a powerful tool to assess structure-permeability
relationships and to test biophysical models for membrane passage. From an applied per-
spective, FARMA can be extended to high-throughput screening by adaption of the micro-
plate reader format, to spatial monitoring of membrane permeation by microscopy imaging,
and to the compartmentalized monitoring of enzymatic activity.
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The permeability of molecules through biological mem-branes is a fundamental physicochemical property, e.g., itallows cells to regulate the influx/efflux of nutrients, neu-
rotransmitters, and pharmaceutical drugs, as well as of xenobio-
tics1–3. Several assays for screening membrane permeability of
potentially bioactive compounds have been developed4–9, two of
which have become routine in pharmaceutical-industrial and
academic settings: the parallel artificial membrane (PAMPA)10–12
and the Caco-2 cell permeability assay13. The cost-efficient
PAMPA assay quantifies the passive diffusion of substances
through macroscopic and flat synthetic membranes, whose
composition has been optimized to model the permeability
behavior of phospholipid-based biomembranes12. The Caco-2
assay aims to identify substances that can pass through a
monolayer of colon epithelial cells, which is highly relevant for
the gastrointestinal uptake. Obstacles are its slow turnaround
time, high cost, and the potential involvement of metabolic
pathways, active transporters or efflux systems4. Importantly,
both the PAMPA and Caco-2 set-ups are usually restricted to
single-point measurements and the results depend strongly on
extrinsic factors, such as the rate of stirring11, which complicates
access to elementary kinetic information.
The permeability of aromatic molecules is of pivotal impor-
tance, because aromatic moieties are ubiquitously occurring in
peptides, hormones, neurotransmitters, toxins, biocides, as well as
colorants and drugs. For instance, ~80% of oral drugs contain at
least one aromatic moiety14. Although aromatic compounds are
chromophoric, and in principle detectable by spectrophotometry,
about 40% of all substances fail ultraviolet visible (UV/Vis)
detection because of low solubility (typically 50–100 μM are
required)11 or insufficient absorbance in the near UV/Vis
region15. Consequently, the development of a sensitive
fluorescence-based permeability assay has been a long-standing
goal16. Frequently, fluorescently labeled analytes have been used
but the attachment of fluorescent tags can drastically influence
the permeability characteristics16,17. Thus, label-free fluorescence-
based permeation assays are sought for but currently limited to
purpose-selected analytes. For instance, dynamic fluorescence
quenching of an encapsulated reporter dye was used for per-
meation monitoring of redox-active analytes at very high (milli-
molar) concentrations18. We showed that an indicator
displacement assay19 can be adopted to monitor membrane
translocation of a label-free highly charged antimicrobial
peptide and selected charged amino acid derivatives through
membrane pores20,21. For this purpose, an environment-
responsive dye is precomplexed with a host to yield a chromo-
phoric or emissive reporter pair. In the presence of a host-binding
analyte, the dye is competitively displaced, giving rise to a
quantifiable signal change. The limitations of indicator displace-
ment assays, most notably its limited scope to strongly binding
and slowly translocating analytes, are described in detail in
the Supplementary Information.
Supramolecular chemists have in recent years designed or
discovered several artificial hosts for biorelevant organic analytes,
e.g., calixarenes, cyclodextrins, cucurbit[n]urils and their acyclic
congeners, pillar[n]arenes, deep cavitands, and molecular twee-
zers22–27. Of particular interest for sensing applications are
fluorescent artificial receptors (FARs) with a wide analyte scope, a
high binding affinity in water, and a rapid analyte-binding
kinetics26. We hypothesized that through encapsulation of such
FARs in liposomes, a FAR membrane assay (FARMA) can be
established that will be capable of monitoring the membrane
passage of a very wide range of label-free, biologically relevant
analytes in real time. The schematic FARMA concept is depicted
in Fig. 1a. In this study, we demonstrate its utility for self-
assembled FARs composed of the macrocycle cucurbit[8]uril
and a tightly bound dicationic reporter dye as the co-factor
(Fig. 1b)26. This system is excellently suited for monitoring the
permeation of aromatic analytes (>100 compounds tested, see
Fig. 2) through a phospholipid bilayer membrane in the biolo-
gically most relevant nM–μM range.
Results
Analyte binding to fluorescent artificial receptors. FARs were
self-assembled in aqueous buffer from the macrocycle cucurbit[8]
uril (CB8) and fluorescent, dicationic dyes D1–D3, forming dis-
crete 1:1 CB8•dye complexes (Fig. 1a)26,28. These FARs possess
residual space in their cavity that serves as a binding pocket for
aromatic moieties, e.g., phenyl, indoyl, and naphthyl species (see
Fig. 1c). Crucial for their use in FARMA, the herein utilized CB8-
dye-based FARs are phospholipid membrane-impermeable and
photostable (see Supplementary Information, e.g., Fig. 9).
The signal response (generally emission quenching)26 of
FAR-1 and FAR-2 towards selected analytes with an aromatic
recognition motif was quantified in homogeneous aqueous
solution by fluorescence titration experiments (see the Supple-
mentary Fig. 1 and Supplementary Table 1). Some analytes show
the appearance of an exciplex emission band when binding to
FAR-3 (see Supplementary Fig. 4). Importantly, the response is
“immediate” even in stopped-flow experiments, suggesting that
FARs are suitable for time-resolved (t ≥ 100 μs) monitoring of
analyte permeation through phospholipid membranes.
Our analyte test library (Fig. 2) contained more than 100 bio-
and drug-relevant compounds with aromatic moieties such as
phenols, anilines, indoles, naphthalenes, polyaromatic hydrocar-
bons, benzimidazoles, alkylated benzenes, halogenated aryl-
species, quinolines, pyridines, and furans (Fig. 2). The analytes
carried a wide spectrum of functional groups, ranging from
electron-donating to electron-withdrawing groups, e.g., –NR2,
–NH2, –OR, –OH, –F, –Cl, –Br, –I, –SH, –OPO32– –COR,
–CONHR, –COOR, –COOH, –SO2NH2, –SO3H, –CN, and
–NO2. Representative analytes with immediate biological rele-
vance are aromatic amino acids (e.g., tryptophan), metabolites
(tryptophanamide, TrpNH2), neurotransmitters (e.g., serotonin),
antibiotics (e.g., penicillin G), drugs (e.g., omeprazole), herbicides
(e.g., propanil), fungicides (e.g., thiabendazole), carcinogenics
(e.g., anthracene), food additives (e.g., raspberry ketone), and
bioactive peptides (e.g., somatostatin). We are unaware of any
alternative method, which allows the direct real-time assaying of
membrane permeability of such a structurally diverse library. In
fact, an adaption of the method to a dye-displacement format
allows for the monitoring of additional aliphatic analytes, e.g.,
adamantane derivatives such as the drug memantine and alkyl
amines such as the metabolite cadaverine (see Figs. 14–17 in
the Supplementary Information).
Implementation of FARs into membrane translocation assays.
Most established drug permeation assays are based on single-
point determinations where the signal is recorded before and after
a fixed time period. To demonstrate that FARMA can effectively
complement these state-of-the-art single-point assays, the fol-
lowing sequence of steps was executed: (1) FARs were encapsu-
lated into phospholipid liposomes formed in aqueous buffer by a
rehydration and freeze–thaw procedure, followed by chromato-
graphic separation of FAR-containing liposomes from non-
encapsulated FARs, see the “Methods.” (2) The purified FAR-
containing liposome suspension was transferred to fluorescence
cuvettes or into microwells and the emission spectra at t= 0 were
recorded. (3) Aliquots of the test analyte were added and the
emission spectra were recorded again after fixed time intervals
(5–60 min).
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Comparison of the fluorescence spectra before and after
analyte addition after a fixed time yielded a pattern that is in
full accordance with the graphical depiction of the FARMA
principle in Fig. 1a: a quenching of the emission intensity of the
FARs was observed for permeating analytes (e.g., naphthalene or
indole) (Fig. 3a, b and Supplementary Fig. 2–4), whereas non-
permeating analytes (e.g., zwitterionic tryptophan) caused no
significant changes in the fluorescence signal (Fig. 3c and
Supplementary Figs. 2 and 3). The FARMA method is
transferable to microplate reader format in disposable and cost-
economic plastic wells (Supplementary Fig. 2).
Several control experiments were carried out to ensure that the
observed fluorescence changes were not due to a disruption of
liposomes caused by the analytes and not due to the leakage of the
FARs (see Fig. 3a, b and the Supplementary Information).
Assay sensitivity. The series of FARMA experiments showed that
an analyte concentration of 10 µM is generally sufficient to dif-
ferentiate between permeating and non-permeating analytes. In
fact, for selected analytes such as indole, phenol, tryptophan
methyl ester (TrpOMe) and tryptamine even nM to low µM
concentrations were sufficient (Figs. 3b and 4, and Supplementary
Fig. 5). Converted to 96-well microplate reader format, the
FARMA sensitivity corresponds to 4–400 ng/well, depending on
analyte. Thus, the sensitivity of FARMA is comparable to estab-
lished mass spectrometry-coupled permeation assay formats and
superior to common absorbance-based permeation assay formats
requiring typically 50–100 μM analyte concentration4,10–13. We
observed that with liposome-encapsulated FARs, analytes can be
detected at least an order of magnitude more sensitively com-
pared to experiments with non-encapsulated FARs in homo-
geneous solution. This sensitivity enhancement through FAR
encapsulation will be also relevant for additional sensing appli-
cations besides permeation monitoring, e.g., for environmental
monitoring.
Time-resolved analyte translocation monitoring by FARMA.
When carrying out the measurements in a time-resolved
manner, i.e., with a continuous recording of the emission
intensity, the permeation process of the analytes through the
phospholipid bilayer membrane becomes observable in real-
time (see the schematics in Fig. 1b and the plotted experimental
data in Fig. 3c–g). This constitutes a major advancement
compared with PAMPA or Caco-2 assays. Depending on the
absolute permeation rates, FARMA kinetics can be either
monitored upon manual mixing with standard fluorometers or
microplate readers (min–h) or by stopped-flow techniques with
fluorescence detection (ms–s). The CB8-dye-based FARs are
useful for monitoring of both slow and fast analyte transloca-
tion kinetics, because FAR•analyte complex formation is very
rapid (up to diffusion limited26) and, thus, not rate-
determining.
As an example of slow translocation kinetics, the permeation of
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Fig. 1 Operational principle of the fluorescent artificial receptor membrane assay (FARMA). a Encapsulation of membrane-impermeable fluorescent
artificial receptors (FARs) into liposomes spatially separates the FARs from the subsequently added analyte. Upon analyte permeation through the
membrane into the liposome, and subsequent rapid analyte complexation by FAR, a readily observable change in the fluorescence intensity of the FAR can
be observed (typically emission quenching). b Expected emission-readout for a permeable vs. an impermeable analyte. c Structures of the synthetic host
CB8 and dyes (D1–D3), from which FAR-1, FAR-2, and FAR-3 were assembled.
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measured with FAR-1 and FAR-2, as well as with two different
dye-displacement strategies. Reassuringly, the normalized kinetic
profiles were superimposable, within error. As an example of very
fast translocation kinetics, a representative stopped-flow data set
is shown in Fig. 3e for the addition of phenol to FAR-2
liposomes. It was found that the observed kinetic traces could be
well fitted by a monoexponential decay model, affording pseudo-
unimolecular rate constants (kobs). As expected, the kobs values
were found to be linearly proportional to the analyte concentra-
tion, at least in a low concentration range (see the Discussion).
The observed kinetic rate constants for 28 structurally related,
non-charged, and rapidly permeating phenol- and aniline-type
analytes were obtained analogously (Supplementary Table 2). The
recovered rate constants span more than three orders of
magnitude in range. Such data can be utilized to compare the
permeation characteristics of different analytes, to uncover
structure–property relations, to derive permeation rate constants
(kp) and to extract apparent permeability coefficients (Papp), see
the “Discussion.”
When compared with PAMPA and Caco-2, our FARMA
method offers access to the entire time course of the permeation
process, which can be employed for detailed mechanistic
investigations of the permeation process. Kinetic investigation
of the more complex case of charged analytes illustrate how the
FARMA method can potentially be used to obtain novel
mechanistic information. Unlike the findings for small, neutral
analytes (Fig. 3), the permeation of charged tryptamine,
TrpNH2, and serotonin led to significant deviations from
monoexponential kinetic traces (see Fig. 3c, d and Supplemen-
tary Figs. 6, and 8g). This is in line with translocation models
for charged species, which predict deviations from simple
monoexponential kinetics on account of co-transport of
counterions or the neutralization of the charge by a prior
deprotonation step29. The lipid composition of the bilayer
membrane can also strongly influence the permeation rates30,31.
Herein, we tested POPC : POPS compositions ranging from 8 : 1
to 15 : 1 (Fig. 3) and the influence of cholesterol as a membrane
component (see Supplementary Fig. 7).
Spatially and temporally resolved FARMA with GUVs. For
specialized permeation assays, it would be desirable to monitor
the permeation kinetics of single membrane-compartmentalized
entities instead of the ensemble average obtained with small FAR-
encapsulated liposomes. We therefore tested whether a spatially
and temporally resolved permeation monitoring is possible with
FARMA. To this end, giant unilamellar vesicles (GUVs), which
can be studied by conventional fluorescence microscopy, were
loaded with FAR-1 using electroformation (see the “Methods”).
To allow direct imaging, we skipped a potential separation step to
remove the non-encapsulated FAR-1 from the buffer medium.
Instead, the non-permeating analyte tryptophan was added to the
media, which saturates the binding sites of the non-encapsulated
FAR-1 and, thus, quenches the extravesicular emission. The inner
compartment of the FAR-1-encapsulated GUVs is not accessible
to the analyte Trp and, thus, it remains emissive (Fig. 3g) and
available for binding of a subsequently added, membrane-
permeable analyte. Indeed, when TrpOMe as a rather quickly
permeating charged analyte (Table 1) was added to the medium
with FAR-1-encapsulated GUV, a loss of the fluorescence
Fig. 2 Chemical structures of compounds investigated in this study. a Benzene derivatives; b amino acid derivatives and peptides; c polycyclic aromatic
and heterocyclic compounds; d pesticides, insecticides, fungicides, herbicides, and antibiotics; e drugs; and f vitamin B1 as well as selected non-aromatic
compounds, for which the alternative dye-displacement strategy was adopted (see the Supplementary Information). The compounds are represented in
their predominant charge state at pH 7. Color code; green: rapidly permeable, black: slowly permeable, and red: impermeable.
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emission from the interior of the GUVs was observed over time,
indicating that TrpOMe reaches the GUV-encapsulated FAR-1
target (Fig. 3g). This sequence of experiments also serves as an
independent, visual verification that the FARs are permanently
encapsulated inside the liposomes, and that lysis of the membrane
upon analyte addition does not occur (see also Supplementary
Fig. 8).
Selective detection of analytes and enzymatic conversions.
Beyond its use for permeation monitoring of drugs and other
biorelevant analytes, FARMA opens up new sensing opportu-
nities, overcoming standing issues related to the low selectivity of
FARs26. For instance, selective detection of permeable species
(e.g., TrpOMe) is possible even in the presence of aromatic amino
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quench the emission of the FAR (see Fig. 3g). Furthermore,
analytes can be also distinguished from each other when their
permeation rates are sufficiently different (see, for instance, the
examples in Supplementary Figs. 9 and 10).
Several charged, non-permeable analytes can be selectively
detected when a suitable enzyme is used in combination with
FARMA (Fig. 4a). For instance, negatively charged, impermeable
aryl-phosphates such 2-naphthyl phosphate (Fig. 4b) are
selectively converted to permeable phenols (e.g., 2-naphthol)
upon addition of the enzyme alkaline phosphatase (ALKP). This
new compartmentalized variant of a supramolecular tandem
enzyme assay32 allows for the detection of down to 300 nM
arylphosphates, while the magnitude of the response is consider-
ably lower in the absence of the protective membrane
(Supplementary Fig. 11). Similarly, the affinities of phenol and
phenyl-β-D-galactopyranoside for FAR-1 are comparable, Kd=
1.8 mM and 3.3 mM, respectively, such that they cannot be
readily distinguished in a homogeneous sensing format. However,
with FARMA, phenol gives an “immediate” signal (t < 5 s, see
Fig. 3e) whereas phenyl-β-D-galactopyranoside provides a slow
response (t > 5min, see Fig. 4c). Upon addition of the enzyme β-
galactosidase (β-gal), a fast hydrolysis of phenol-substituted β-D-
galactopyranoside occurs28, upon which the phenol product
quickly permeates through the membrane and binds to FAR-1
(see Fig. 4a). Besides, information about the enzymatic reaction
rate can be derived at the same time from the enzyme-coupled
FARMA experiments. The membrane-mediated spatial separa-
tion of FARs from the enzymes ensures native functionality and
catalytic activity of the enzyme. Finally, with FARMA, enzymatic
reaction monitoring is feasible at lower substrate concentration
than in homogeneous FAR-based sensing formats.
Discussion
The FARMA method affords information-rich kinetic permeation
profiles as the primary output. These can be directly compared
with each other to rank the membrane permeation characteristics
of different analytes. The relative permeation characteristics
extracted in this way suffice for the majority of envisioned
practical applications of FARMA, e.g., when testing drug
candidates.
From the permeation screening experiments, analytes can be
divided into non-permeating, slowly permeating, and rapidly
permeating (see color codes in Fig. 2 and in Supplementary
Table 3). Almost all neutral and positively charged species were
found to be readily membrane permeable, unless they are polar
and large (such as peptides), very hydrophilic (such as
Fig. 3 Temporally and spatially resolved FARMA experiments. a Emission spectra of FAR-1-loaded liposomes prior and after addition of naphthalene
(ethanolic stock); addition of neat ethanol is shown as the control. b Emission intensity of FAR-2-loaded liposomes upon addition of indole (aq. stock);
control exp. with D1-loaded liposomes are shown in blue. c Time-resolved translocation monitoring of tryptophan (Trp) and tryptophanamide (TrpNH2),
both 8 µM from aq. stock, with FAR-1-loaded liposomes (POPC : POPS 8 : 1, 10 mM HEPES buffer, 22 °C). d Translocation monitoring of tryptamine (aq.
stock, 16 µM) with FAR-1- and FAR-2-loaded liposomes, and with two membrane-encapsulated indicator displacement ensembles (blue and green, see
Supplementary Information). Experiments were conducted with POPC : POPS 8 : 1 liposomes in 10mM HEPES buffer at 22 °C. e, f Kinetic traces from
stopped-flow experiments for rapid mixing (1 : 1 v/v) of phenol (aq. stock) with FAR-2-loaded liposomes (POPC : POPS 8 : 1, 10 mM HEPES buffer, 22 °C).
f Plot of kobs, from monoexponential fits of kinetic traces vs. phenol concentration. g Time series of fluorescence microscopy images of a FAR-1-loaded
GUV after addition of 5 µL tryptophan methyl ester (TrpOMe, 800 µM stock) to the medium, as real-color images (top) and as intensity-coded images






































































Fig. 4 Enzyme-coupled FARMA method. a Schematic operational principle and representative enzymatic reactions. b Time-resolved emission of liposome-
encapsulated FAR-1 with the membrane-impermeable substrate 2-naphthyl phosphate and the enzyme alkaline phosphatase (ALKP, 16 µg ml−1).
Experiments were conducted with POPC : POPS (8 : 1) liposomes at 22 °C. c Time-resolved emission of liposome-encapsulated FAR-1 and the slowly
permeating substrate phenyl-β-D-galactopyranoside, with and without the enzyme β-galactosidase (β-gal, 43 µgml−1). Experiments were conducted with
POPC : POPS (8 : 1) liposomes at 22 °C.
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dopamine), or dicationic, such as paraquat (viologen), or the dyes
D1–D3 themselves. Representative kinetic traces are shown in
Fig. 3 and Supplementary Figs. 5, 9, and 10.
The positively charged neurotransmitters tryptamine, tyr-
amine, and serotonin were shown to pass the membrane within
several minutes to hours. Expectedly, the more hydrophilic spe-
cies permeate more slowly, e.g., phenethylamine > tyramine
(Supplementary Fig. 9f) and tryptamine > serotonin (Supple-
mentary Fig. 5 vs. 9g). The catecholamine neurotransmitters
dopamine and adrenaline (epinephrine) are very slowly per-
meating through the biomembrane, whereas the parent catechol
is “instantaneously” permeating (Supplementary Fig. 9f).
Almost all anionic species were found to be phospholipid
membrane-impermeable (Supplementary Table 2 and Supple-
mentary Figs. 9 and 10), which is in agreement with expectation
(e.g., for aromatic amino acid derivatives33 or ampicillin34) and
rationalized by the Columbic repulsion between the analyte and
the negatively charged bilayer biomembrane. The “hydrophobic
anion” 2-adamantyl-carboxylate is a noteworthy exception; it is
membrane-permeable, albeit at a slower rate than its non-charged
(2-adamantanol) and positively charged (2-ammonium-ada-
mantane) analogs (see Supplementary Figs. 16 and 17). In fact,
lipidization of drugs through connection to adamantyl moieties is
a known approach to increase their membrane permeability and,
thus, bioavailability35.
To rationalize the permeation rate trends of structurally simple,
non-charged aromatic species (Supplementary Table 2), the
molecular van der Waals volume (vdW volume, VW) of the
analyte and the logP values—a measure for the lipophilicity of an
analyte—were employed as descriptors. For example, the per-
meability of phenol (logP= 1.64) is 20 times lower than that of
toluene (logP= 2.52), which is in line with lipophilicity differ-
ences36. Furthermore, an inverse relationship between the vdW
volume and the permeability is observed for the subset of para-
alkylated or halogenated phenols, i.e., the kobs are ordered as H >
Me > Et > tBu and F ≥H > Cl > Br > I. However, interesting
exceptions were also observed; 4-tert-butylphenol is more lipo-
philic and smaller than propanil but permeates three orders of
magnitude more slowly. Indeed, it has been proposed that highly
lipophilic molecules (logP > 3) can be retained in the lipid
membrane and, therefore, exit the membrane slowly, causing an
overall decrease in the observed analyte translocation rate37.
When attempting to correlate the permeation rates with the
logP and VW values for the whole set of 28 small-molecule aro-
matics, it becomes immediately obvious that a simplified
structure–activity relationship using the lipophilicity and size of
the permeating species does not exist (see Fig. 5). Such coun-
terintuitive behavior exemplifies the complexity of the passive
diffusion through a membrane for which FARMA can provide
useful experimental benchmark data.
Elementary physical parameters, such as permeability coeffi-
cients, can be extracted from the full kinetic FARMA data. This
kinetic profile → parameter mapping requires some assumptions
to be made in regard to the permeation mechanism. We applied a
reported permeation model for liposomes31 to arrive at per-
meation rate constants (kp) and apparent permeability coeffi-
cients (Papp). The derivation of the mathematical relation (1),
linking the fundamental permeability rate constant and
Table 1 Permeation rates (kp) and apparent permeability coefficients (Papp) for the permeation of charged analytes through
liposomal POPC : POPS (8 : 1) bilayer membranes (r ca. 100 nm),a ordered from slowest to fastest permeability coefficient.
Analyte kp/(10−2 s−1) Papp/(10−6 cm s−1)
This workb This workb Literaturec Assay/lipid type




Serotonin 0.12f 0.004f 1.1 Aliquot analysis/flat lipid bilayer
















Aliquot analysis/flat lipid bilayer
Fluorescence quenching








TrpOMe 190 6.4 - - -
Memantine 720 24 43 Caco-2





Aliquot analysis/flat lipid bilayer
Phenol 3400 112 47 PAMPA
4Cl-aniline 5000f 170f 42 PAMPA
Aniline 9400f 310f 76 PAMPA
4CN-phenol 50,000f 1700f 17 PAMPA
aObtained by the FARMA method with a receptor concentration of ca. 500 μM (500 μM CB8 and 550 μM dye) at 22 °C; entries 4Cl-aniline, aniline, and 4CN-phenol correspond to Supplementary
Table 2.
bValue obtained by Eq. (1), taking the slopes kobs/canalyte from the linear fit of kobs vs. canalyte in the linear range, i.e., canalyte≤ 20 μM, unless stated otherwise, 20% error (reproducibility).
cLiterature values taken from the following references: end-point analysis/EPC liposomes31, aliquot analysis/flat lipid bilayer30, Caco-242, PAMPA38,40,43, and fluorescence quenching18. For memantine,
Papp was taken from ref. 44 for Caco-2.
dNo permeation observed up to 100 μM.
eNo passive permeation but active transport.
fValues from single-point measurements according to Eq. (1) at 40 µM analyte concentrations, except for serotonin (16 µM) and ranitidine (100 µM).
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permeability coefficient to experimental measurable kobs rate
constants, the known total analyte and total FAR concentration,
and the experimentally determined liposome radius (r), is shown
in the Supplementary Information.
Papp ¼ kp  r=3ð Þ ¼ kobs=canalyte  cFAR  r=3ð Þ ð1Þ
The volume-to-surface correction factor r/3 accounts for the
fact that the observed rates depend on the size, i.e., radius r, of the
liposomal assembly31. Experimentally, the ratio kobs/canalyte can be
obtained as the slope of the plot of kobs against canalyte, as is shown
in Fig. 3f for phenol as the analyte, and in Supplementary Fig. 12
for indole, tryptamine, TrpOMe, and N-acetyl tryptophanamide
(NATA). The initial-rate method can also be applied,
see the Supplementary Information. Moreover, kobs/canalyte can be
estimated by single-point measurements at selected canalyte
concentration.
Representative permeation rate constants (kp) and permeability
coefficients (P) obtained through Eq. (1) are listed in Table 1 for
selected analytes for which literature P-values were available. The
kobs, kp, and Papp values for a series of 28 phenols and anilines is
given in Supplementary Table 2.
The obtained permeability coefficients shown in Table 1
compare favorably with ranges of literature values obtained by
other methods for neutral analytes with comparable molecular
weight38. For instance, the Papp value (all in 10−6 cm s−1) for
indole determined by FARMA in liposomal POPC : POPS bilayer
membranes (106) lies within the range of values extracted from
PAMPA in synthetic membranes (32)39, by Caco-2 assay (57)40,
and for a macroscopic bilayer of brain phospholipids (250)30.
Likewise, when comparing the Papp values for other non-charged
analytes, a good qualitative agreement is found, e.g., for NATA,
where the FARMA value (1.0) lies between that determined by
fluorescence quenching (0.1), PAMPA (1.9), and Caco-2 (2.5).
For the drug memantine, the FARMA value (24) is close to the
reported Caco-2 based value (43). However, for charged and
rather hydrophilic substances, our setup yields consistently lower
permeabilities than PAMPA and Caco-2. For instance, for tryp-
tamine, our value determined by FARMA in liposomal POPC :
POPS bilayer membranes (0.19) comes close to that obtained by
fluorescence quenching experiments (0.33) but falls one order of
magnitude short to that of PAMPA and other flat lipid mem-
branes (Table 1). Similar findings were made for TrpNH2, rani-
tidine, and serotonin, which all show an order of magnitude faster
permeation under PAMPA and Caco-2 conditions than in our
POPC : POPS bilayer membranes. Conversely, for non-charged
lipophilic aromatics, we mostly observed faster permeation in our
POPC : POPS bilayer membranes than reported under PAMPA
conditions, e.g., compare the series of phenols and anilines. These
differences point to a specific mechanistic involvement of the
different membrane lipids in the permeation process.
It transpires that the FARMA method affords absolute per-
meability coefficients, which are comparable with those deter-
mined by established methods. Differences may be traced back to
the use of flat hexadecane membranes (PAMPA) vs. spherical
phospholipid bilayers (FARMA), potential complications arising
from transporters (Caco-2), and saturation effects occurring at
higher analyte concentration (usually not considered for PAMPA
and Caco-2 but uncovered by FARMA). The use of different
buffers and pH as well the different lipid compositions and types
also contributes to the variations.
In conclusion, the FARMA method allows real-time optical
monitoring of the permeation of a large variety of drugs, toxins,
and other organic compounds, circumventing the need for
labeled analytes16,17, bypassing methodologies limited to analyte-
induced pH jumps41, circumventing single-point mass-spectro-
metric detection15, and complementing alternative assays in
membrane research such as PAMPA10–12 or Caco-213. Important
to note, FAR-based membrane assays allow accessing the entire
kinetic traces even for the most rapid permeation events. Fur-
thermore, the FARMA procedure can be modified to allow real
spatial resolution to microscopically follow analyte uptake. Owing
to the use of fluorescence for detection, flexible implementation
into microplate and confocal imaging formats are readily per-
formed. Furthermore, different FARs can be adopted that vary
with respect to analyte scope, sensitivity, selectivity, and excita-
tion, as well as emission wavelengths. Preliminary experiments
have shown that the method is transferable to different lipids
such as dipalmitoylphosphatidylcholine, dioleoylphosphatidylcho-
line, and dioleoylphosphatidylserine, which allows access to the
future investigation of permeation rates in dependence on tem-
perature and lipid-phase type.
We therefore contend that FARMA will become a com-
plementary tool both in fundamental and applied membrane
permeation research.
Methods
Materials. Analytes, buffers, and lipids were purchased from Alfa Aesar and
Sigma Aldrich, and were used as received. Peptides were purchased from BIO-
SYNTAN GmbH. Hosts CB7 and CB8 were purchased from Strem. Dyes D1–D3
were prepared according to literature procedures (see ref. 26 and references
therein). Dyes 2,6-ANS and DapoxyS, which were utilized for the dye-displacement
assay described in the Supplementary Information, were purchased from
Invitrogen.
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Fig. 5 Structure-permeability relationships. Observed permeation rate constants (kobs) for small aromatics, e.g., phenols and anilines (color-coded from
blue= fastest to red= slowest permeating on a logarithmic scale) correlated to their logP values (x axis) and their van der Waals volumes (VW, y axis).
The numbering of the compounds follows their order of permeation speed from 1= fastest to 28= slowest. See Supplementary Table 2 for the numerical
kobs, logP, and VW values.
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Preparation of FARs. The chemosensors FAR-1, FAR-2, and FAR-3 were self-
assembled from the host CB8 and the dyes D1, D2, and D3, respectively, by
dissolving the solid materials together in HEPES buffer (10 mM, adjusted to pH
7.0) to reach 500 µM in CB8 and 550 µM in the dye component (a slight excess of
dye was used to ensure full complexation of the host). The dissolution process was
assisted by heating to 40–50 °C and the use of a sonication bath.
Determination of binding constants for FAR-analyte pairs. Fluorescence titra-
tions were carried out in aqueous HEPES buffer (10 mM, pH 7, 22 °C) unless stated
otherwise. To a solution of the FAR (typically at 10–30 μM) was stepwise added a
solution of the analyte (typically up to 2 mM) and the fluorescence spectra were
recorded. The normalized emissions at 450 nm (FAR-1) or at 370 nm (FAR-2)
were fitted with an equation for a 1 : 1 binding by a least-square fit. The resulting
affinity constants are reported in Supplementary Table 1. Representative titration
plots are shown in Supplementary Fig. 1. Note that the high CB8-dye binding
affinities correspond to a near quantitative degree of host-dye complexation, i.e.,
quantitative formation of the FAR, such that the subsequent binding of the analyte
can be treated independently.
Liposome preparation and FAR encapsulation procedure. A solution of 2.5 mg/
mL of POPC and 0.33 mg/mL of POPS in chloroform was purged with nitrogen
and dried overnight under high-pressure vacuum. The lipid film was rehydrated
with 1 mL HEPES buffer (10 mM) containing FAR (0.5 mM, prepared from 500
µM in CB8 and 550 µM in the dye component in HEPES buffer, see above) fol-
lowed by 13–15 freeze–thaw cycles (freeze in liquid nitrogen, thaw at 40 °C in a
water bath). The resulting FAR-loaded liposomes were separated from non-
encapsulated species by size-exclusion chromatography (NAP-25 column), while
maintaining the same buffer. The absence of non-encapsulated FAR was confirmed
by adding a non-membrane-permeable species such as tryptophan to a fluores-
cence cuvette containing 25 µL of liposomes diluted in 1 mL HEPES (10 mM)
buffer. Complete removal of non-encapsulated FAR is indicated by the absence of a
significant fluorescence change upon Trp addition. The size of the liposomes (r ~
100 nm) was measured by dynamic light scattering (Zetasizer Nano from Malvern
Instruments).
FARMA procedure. In a typical experiment, 20 µL of liposome solution loaded
with FAR was diluted in 1 mL HEPES buffer (10 mM, pH 7.0) in a 1 mL quartz
cuvette. An emission spectrum was recorded after 10 min of “equilibration time”
on a Varian Eclipse spectrofluorometer thermostated at 22 °C with a water bath
using λexc= 400 nm for FAR-1, λexc= 310 nm for FAR-2, and λexc= 330 nm for
FAR-3. In the time-resolved experiments, the emission intensity at λobs= 450 nm
for FAR-1, λobs= 370 nm for FAR-2, and λobs= 370 and 500 nm for FAR-3 (the
latter is the emerging excimer band for certain FAR-3•analyte complexes) was
recorded with an averaging time of 0.5 s. Once the signal had stabilized, 8 µL of a 1
mM analyte solution in the same buffer (HEPES, 10 mM) was added (cfinal= 8 µM)
to the cuvette and the emission monitoring was continued until no significant
change occurred. For single-point experiments, a full spectrum was recorded after a
fixed time or several time intervals after analyte addition. Control experiments
confirmed that the autofluorescence of each analyte at the given excitation and
emission wavelength for a FAR was unnoticeable or small and could be corrected
for. It was also confirmed by UV/Vis spectroscopy that the absorbance of the
analyte at the given excitation wavelength of the FAR is low (Abs < 0.05), such that
inner filter effects are also negligible. Only FAR-analyte combinations were used for
FARMA, for which no significant autofluorescence and competitive light absorp-
tion of the analyte occurred.
Microplate measurements were performed with a JASCO FP-8500
spectrofluorometer coupled with a JASCO FMP-825 microplate reader accessory in
96-well microplates at ambient temperature, using flat-bottom black microplates
with a nonbinding surface. After filling with liposome solution (200 μL), the
microplate was placed into the reader and equilibrated for 10 min. Then,
fluorescence intensity of each well was recorded, followed by analyte addition and
subsequent fluorescence recording at specific time intervals.
Time-resolved FARMA for rapidly permeating analytes. Stopped-flow experi-
ments were performed with a Bio-Logic stopped-flow SFM-20 module coupled to a
JASCO FP-8500 spectrofluorometer at 22 °C. In a standard experimental setup, 400 µL
of a FAR-2-loaded liposome solution was diluted in 10mL of 10mM buffer in Syringe
1, while Syringe 2 contained phenol at different concentrations, between 2 and 80 µM.
Fluorescence measurements were initiated by mixing the contents of the two syringes
in equal volumes (total volume= 200 µL, flow speed of 4.5mL/s) in the stopped-flow
chamber, such that the final phenol concentration range for measurement was 1–40
µM. All experiments were carried out in 10mM HEPES buffer, pH 7.0, at 20 °C.
Fluorescence intensities were recorded with an excitation wavelength of 310 nm and
emission at 350 nm. For each experiment, measurements from 6 injections were
accumulated and the average of these traces was used for data analysis.
Spatially and temporally resolved FARMA with GUVs. GUVs were prepared
using Vesicle Prep Pro from Nanion Technologies. Specifically, a mixture of a 30
µL POPC solution (25 mg/mL in CHCl3) and 10 µL POPS solution (5 mg/mL in
CHCl3) was spread as a thin film on ITO-coated glass slides. After the solvent had
evaporated and the film had dried, it was rehydrated with 300 mM of sucrose
solution containing FAR-1 and covered with another ITO slide. After 2 h of pre-
paration in Vesicle Prep Pro, GUVs had formed and the suspension was collected.
All subsequent measurements were carried out on the same day: a drop of the GUV
suspension was pipetted on a glass slide and the formation of GUVs was confirmed
by bright-field microscopy (Supplementary Fig. 8). To this suspension, 5 µL of
tryptophan (1 mM stock) was added to quench the fluorescence of the FAR-1
chemosensing ensemble. Fluorescence images of such treated GUVs were taken
with a fluorescence microscope (Axiovert 200, Carl Zeiss, filter set 02, i.e., G 365
nm, FT 395 nm, and BP 420 nm), equipped with a digital camera (Evolution QEi
monochrome). The first image was taken immediately after the addition of 5 µL of
TrpOMe (800 µM stock) to the suspension. Subsequent images were taken at
regular intervals (1 min) thereafter. Constant illumination was avoided to reduce
potential photobleaching, i.e., the sample was illuminated only when the images
were taken. Exposure time and camera settings were constant across all images.
Images were analyzed by using the Image J software. To ensure that the apparent
decrease in fluorescence over time was not due to photobleaching of the dye,
experiments were carried out exactly as described above, except for the addition of
TrpOMe. Indeed, in the absence of TrpOMe, no noticeable change in fluorescence
intensity was observed (Supplementary Fig. 8).
FARMA-coupled enzymatic experiments. The hydrolysis of 2-naphthyl phos-
phate by alkaline phosphatase (ALKP) from bovine intestinal mucosa (activity of
~2000 units/mg according to supplier) was monitored by emission spectroscopy
(λexc= 420 nm, λem= 450 nm) with FAR-1 at 37 °C following literature proce-
dures28. In analogy to the FARMA procedure, 20 µL of liposome solution loaded
with FAR-1 was diluted in 1 mL HEPES buffer (10 mM, pH 7.5) in a 1 mL quartz
cuvette. Once the emission signal had stabilized, the required volume of a 1 mM 2-
naphthyl phosphate solution in the same buffer was added to reach a final substrate
concentration between 310 nM and 5 µM in the cuvette. After a ca. 1 min equili-
bration time, ALKP stock solution was added to reach an enzyme concentration of
16 µg ml−1 in the cuvette. The emission recording was continued until no sig-
nificant change occurred anymore (after ca. 5 min). The control experiments in
homogeneous solution, i.e., in the absence of a protective membrane, were con-
ducted analogously, employing 5 µM FAR-1 and 5 µM to 30 µM 2-naphthyl
phosphate (see also Supplementary Fig. 11a).
The hydrolysis of phenyl-β-D-galactopyranoside by β-gal from Aspergillus
oryzae (activity of 8 units/mg according to supplier) was conducted
analogously, but at 22 °C28. Phenyl-β-D-galactopyranoside (1 mM) solution
was added as substrate to reach a final substrate concentration between 0 and
2.5 µM in the cuvette, and, after ca. 1 min equilibration time, β-gal stock solution
was added to reach an enzyme concentration of 43 µg ml−1 in the cuvette.
The recording was continued until no significant change occurred anymore
(after ca. 10 min). The control experiments in homogeneous solution employed
5 µM FAR-1 and 10µM phenyl-β-D-galactopyranoside (see also Supplementary
Fig. 11b).
Statistics and reproducibility. Permeation coefficients were based on fitting of
real-time fluorescent decay traces with a large number (>100) of data points. No
randomization or blinding was used. Reported errors were estimated from the
reproducibility, which was checked for representative kinetic experiments by the
same and by different operators.
Reporting summary. Further information on research design is available in the Nature
Research Life Sciences Reporting Summary linked to this article.
Data availability
Source data for Figs. 3, 4, and 5 are available as Supplementary Data 1, 2, and 3,
respectively. All other data are available from the corresponding authors upon reasonable
request and are digitally stored on the severs of the home institution.
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